Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Propranolol Hydrochloride Extended-Release Capsules, USP Rx only
Medication labelWhy this: Advisory · dailymed-prescription
Propranolol Hydrochloride Extended-Release Capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochloride Extended-Release Capsules are not indicated in the management of hypertensive emergencies. Propranolol Hydrochloride Extended-Release Capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Propranolol Hydrochloride Extended-Release Capsules are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Propranolol Hydrochloride Extended-Release Capsules improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.
- generic_name
- propranolol hydrochloride
- product_names
- propranolol hydrochloride
- ndc
- 71335-1765, 0527-4116, 71335-1765-1, 71335-1765-2, 71335-1765-3, 71335-1765-4, 71335-1765-5, 71335-1765-6, 71335-1765-7
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en